Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
about
Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral AnticoagulantsDOACs - advances and limitations in real worldEffectiveness and safety of dabigatran versus warfarin in "real-world" Japanese patients with atrial fibrillation: A single-center observational studyTrends in physiological coagulation factors in Japanese patients receiving novel oral anticoagulantsRisk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies.Overcoming global challenges in stroke prophylaxis in atrial fibrillation: The role of non-vitamin K antagonist oral anticoagulants.The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature.Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation.Risk of gastrointestinal bleeding during anticoagulant treatment.Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin.Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation.The Application and Future of Big Database Studies in Cardiology: A Single-Center Experience.Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study.Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation.Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation.Continuity of care with physicians and risk of subsequent hospitalization and end-stage renal disease in newly diagnosed type 2 diabetes mellitus patients.
P2860
Q26750467-065C1262-1148-4075-87B3-26D68C820A69Q28070132-8F939BC2-5090-4DC2-A975-DD04AFAF1B63Q33552976-14D4A758-B7E8-4B5C-9DC6-A5B7B115B434Q33552982-15013BE8-0A7F-4A12-9053-1D7F0E1516EEQ38712351-72874C2F-805F-4AEE-B60D-A7EDF6578932Q38972270-9A33C04A-9407-4CF0-B473-88B34BE006BEQ39022742-51E4875C-FABB-46EE-8587-CE6DB1EDB5E7Q39129273-00C4A841-71D4-43E8-82D1-3D374B02BB3FQ39280394-ED7F8F2D-672B-43D2-9506-DFDF321D8C75Q42113819-352C05C6-D430-45BA-9864-3F849D17EBFBQ43844039-40E5902C-DC97-4933-8A0D-A8874F534177Q46769776-AB8EAD64-9F13-46D1-AC7E-667E096EBA95Q47874270-F965C813-0EE7-4EEE-AA4F-78BCA14A3C78Q49189865-7D2FB748-DDB8-4E2A-964D-DE3C9A890D29Q50003159-A91FD1A6-07CE-4BEB-A6D7-19C52BD82FBCQ52603891-0D024E94-D5DE-4FCC-8D82-8A63EA27E98DQ55005160-3380505F-EDAA-4FE8-8842-B2FB0199144F
P2860
Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cardiovascular, Bleeding, and ...... nvalvular Atrial Fibrillation.
@en
type
label
Cardiovascular, Bleeding, and ...... nvalvular Atrial Fibrillation.
@en
prefLabel
Cardiovascular, Bleeding, and ...... nvalvular Atrial Fibrillation.
@en
P2093
P1433
P1476
Cardiovascular, Bleeding, and ...... onvalvular Atrial Fibrillation
@en
P2093
Chi-Tai Kuo
Hsin-Fu Lee
Hui-Tzu Tu
Kun-Chi Yen
Lung-Sheng Wu
Shang-Hung Chang
Yi-Hsin Chan
Yung-Hsin Yeh
P304
P356
10.1161/STROKEAHA.115.011476
P407
P50
P577
2016-01-05T00:00:00Z